Home > Healthcare > Medical Devices > Surgical Devices > Endoscopy Fluid Management Market

Endoscopy Fluid Management Market Share

Report ID: GMI4281
Published Date: Jan 2024
Report Format: PDF

Download Free Sample

Endoscopy Fluid Management Market Share

The endoscopy fluid management industry is an oligopoly in nature, with major organizations, local small players, and start-ups joining the industry competition. The development and launch of novel advanced products based on different technologies are among a key market strategy. Some of the leading industry players including Arthrex, Inc., Richard Wolf GmbH, KARL STORZ SE & Co. KG, and Smith & Nephew, among others have a notable presence in the market.

Endoscopy Fluid Management Market Companies

Some of the eminent market participants operating in the endoscopy fluid management industry include:

Arthrex, Inc.
B. Braun SE
CONMED Corporation
Hologic Inc.
Johnson & Johnson
KARL STORZ SE & Co. KG
Medtronic plc
Olympus Corporation
Richard Wolf GmbH
Smith & Nephew
STERIS plc
Stryker Corporation

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global endoscopy fluid management industry was valued at around USD 866.6 million in 2023 and is expected to expand at a CAGR of 7.2% during 2024-2032, attributed to the increasing prevalence of chronic diseases requiring endoscopic procedures, coupled with the rising demand for minimally invasive procedures.

The endoscopy fluid management systems segment is expected to record over 84.4% market share in 2023 and is anticipated to witness significant growth through 2032 as these systems prioritize patient safety by incorporating features that minimize the risk of fluid-related complications.

North America endoscopy fluid management industry accounted for USD 290.4 million in 2023 and is predicted to witness substantial arket growth through 2032 driven by the increasing disease prevalence, a preference for minimally invasive procedures, strong healthcare infrastructure, and adherence to regulatory standards.

Arthrex, Inc., B. Braun SE, CONMED Corporation, Hologic Inc., Johnson & Johnson, KARL STORZ SE & Co. KG, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Smith & Nephew, STERIS plc, and Stryker Corporation.